We are pleased to share a new strategic partnership with Cytosens, a leading distributor of life science technologies in Italy.
About Our Partner: Cytosens
Founded in 2018 as a spin-off of MMBiotech, Cytosens is dedicated to advancing life science research by bringing top-tier technologies to market. With a vision to drive scientific progress, Cytosens has become a trusted name for life science solutions in Italy, consistently anticipating the evolving needs of the research community. Cytosens leverages years of experience and deep expertise in the field to deliver transformative tools across the life sciences, making them an ideal partner for bringing HAWK Biosystems’ technology to Italian researchers.
Empowering Italian Researchers with QF-Pro® Technology
Our collaboration with Cytosens will enable researchers across Italy to access HAWK Biosystems’ QF-Pro® technology. QF-Pro® offers unparalleled sensitivity in protein function analysis, enhancing applications in immuno-oncology, cell therapies, and more. By partnering with Cytosens, we are providing Italian scientists with localised access to our state-of-the-art tools and the comprehensive support needed to advance their research endeavours.
A Shared Commitment to Innovation and Discovery
As Cytosens expands its portfolio to include HAWK Biosystems’ solutions, Italian researchers will benefit from direct access to our cutting-edge spatial biology platforms, supported by Cytosens’ team of local experts. This partnership aligns with Cytosens’ mission to bridge current research needs and future discoveries, reinforcing our shared dedication to propelling scientific innovation and driving progress in biotechnology.
Looking Forward to Future Success
With Cytosens as our partner in Italy, we are excited to embark on this journey to equip Italian biotech companies and researchers with powerful new tools for discovery.
